Hoth Therapeutics has shared some exciting news from their ongoing cancer trial. The company is testing a treatment called HT-001 on patients who are also taking EGFR inhibitor therapy. The results so far are quite impressive. In the trial, every patient who could be evaluated showed a positive res
Breast cancer affects many people. But when it comes to clinical trials, some groups are missing. Black and Hispanic patients are not as likely to join these trials. This is a problem. It makes it hard to give fair care to everyone. There are reasons for this gap. Understanding these reasons i
Imagine trying to find out about cancer trials. It's like searching for a needle in a haystack. Most people don't know much about them, and what they do know might be wrong. This lack of knowledge is a big problem. Fear and confusion often stop people from joining these trials. But here's a
